Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Branford

Showing results (1-10 of 480) with videos related to

Pageof 48
Sort By:
Blood|November 25, 2021
Taming the gatekeeper: ponatinib dose holds the keySusan Branford
British Journal of Haematology|February 3, 2022
BCR::ABL1 transcripts and clinical outcome - interrogating the techniqueSusan Branford
Journal of Intellectual Disability Research : JIDR|August 1, 1996
A review of antipsychotic drugs prescribed for people with learning disabilities who live in LeicestershireD Branford
Hematology. American Society of Hematology. Education Program|November 21, 2007
Chronic myeloid leukemia: molecular monitoring in clinical practiceSusan Branford
Hematology. American Society of Hematology. Education Program|December 13, 2012
Monitoring after successful therapy for chronic myeloid leukemiaSusan Branford
Journal of the Royal Society of Health|August 1, 1991
Pharmaceutical services to the mentally illD Branford
Journal of Intellectual Disability Research : JIDR|August 1, 1997
A follow-up study of prescribing for people with learning disabilities previously in National Health Service care in Leicestershire, EnglandD Branford
Hematology. American Society of Hematology. Education Program|December 4, 2016
Molecular monitoring in chronic myeloid leukemia-how low can you go?Susan Branford
Journal of Intellectual Disability Research : JIDR|December 1, 1994
A study of the prescribing for people with learning disabilities living in the community and in National Health Service careD Branford
Haematologica|October 15, 2020
Why is it critical to achieve a deep molecular response in chronic myeloid leukemia?Susan Branford
Pageof 48

Showing results (1-10 of 480) with videos related to

Sort By:
Pageof 48
Blood|November 25, 2021
Taming the gatekeeper: ponatinib dose holds the keySusan Branford
British Journal of Haematology|February 3, 2022
BCR::ABL1 transcripts and clinical outcome - interrogating the techniqueSusan Branford
Journal of Intellectual Disability Research : JIDR|August 1, 1996
A review of antipsychotic drugs prescribed for people with learning disabilities who live in LeicestershireD Branford
Hematology. American Society of Hematology. Education Program|November 21, 2007
Chronic myeloid leukemia: molecular monitoring in clinical practiceSusan Branford
Hematology. American Society of Hematology. Education Program|December 13, 2012
Monitoring after successful therapy for chronic myeloid leukemiaSusan Branford
Journal of the Royal Society of Health|August 1, 1991
Pharmaceutical services to the mentally illD Branford
Journal of Intellectual Disability Research : JIDR|August 1, 1997
A follow-up study of prescribing for people with learning disabilities previously in National Health Service care in Leicestershire, EnglandD Branford
Hematology. American Society of Hematology. Education Program|December 4, 2016
Molecular monitoring in chronic myeloid leukemia-how low can you go?Susan Branford
Journal of Intellectual Disability Research : JIDR|December 1, 1994
A study of the prescribing for people with learning disabilities living in the community and in National Health Service careD Branford
Haematologica|October 15, 2020
Why is it critical to achieve a deep molecular response in chronic myeloid leukemia?Susan Branford
Pageof 48